Table 3. Microsatellite Alterations in... | American Society of Hematology

Table 3.

Microsatellite Alterations in Leukemia and Lymphoma

Patient No.	Disease	Microsatellite Marker
Patient No.	Disease	D2s123	D9s126	D10s197	VWA	D15s212	D15s161	D18s61	D18s65	AR	DXs1217
213	AML M1			MSI	LOH	MSI	MSI	MSI	LOH	MSI	MSI
702	AML M2									MSI	LOH
739	AML M3			MSI
32	Pre-B ALL	MSI	MSI			MSI		MSI	LOH	MSI	LOH
63	Pre-B ALL	MSI			MSI
74	B ALL					LOH	LOH		MSI
509	T ALL		MSI		MSI			MSI	MSI	MSI	MSI
619	B ALL			MSI							MSI
VR5	T ALL	MSI	MSI	MSI		LOH	LOH	LOH	LOH
11	NHL					MSI	MSI
52	NHL			MSI
23	NHL						MSI	MSI
298	NHL						MSI

Patient No.	Disease	Microsatellite Marker
Patient No.	Disease	D2s123	D9s126	D10s197	VWA	D15s212	D15s161	D18s61	D18s65	AR	DXs1217
213	AML M1			MSI	LOH	MSI	MSI	MSI	LOH	MSI	MSI
702	AML M2									MSI	LOH
739	AML M3			MSI
32	Pre-B ALL	MSI	MSI			MSI		MSI	LOH	MSI	LOH
63	Pre-B ALL	MSI			MSI
74	B ALL					LOH	LOH		MSI
509	T ALL		MSI		MSI			MSI	MSI	MSI	MSI
619	B ALL			MSI							MSI
VR5	T ALL	MSI	MSI	MSI		LOH	LOH	LOH	LOH
11	NHL					MSI	MSI
52	NHL			MSI
23	NHL						MSI	MSI
298	NHL						MSI

The leukemia patients showing either MSI or LOH at the indicated loci are listed. Overall, 29 patients with AML and 37 patients with lymphoid tumors (16 ALL and 21 NHL) were studied for microsatellite alterations.

View Large

This Feature Is Available To Subscribers Only